Charles River Laboratories
554 hedge funds and large institutions have $7.96B invested in Charles River Laboratories in 2025 Q1 according to their latest regulatory filings, with 70 funds opening new positions, 187 increasing their positions, 238 reducing their positions, and 133 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
554
Holders Change
-75
Holders Change %
-11.92%
% of All Funds
7.53%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
70
Increased
187
Reduced
238
Closed
133
Calls
$106M
Puts
$125M
Net Calls
-$19.4M
Net Calls Change
+$1.4M
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
+$309M |
| 2 |
Goldman Sachs
New York
|
+$121M |
| 3 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$81.1M |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$71.1M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$53.2M |
Top Sellers
| 1 |
Koshinski Asset Management
Decatur,
Illinois
|
-$234M |
| 2 |
MG
Meritage Group
San Francisco,
California
|
-$198M |
| 3 |
SCA
Southpoint Capital Advisors
New York
|
-$111M |
| 4 |
BlackRock
New York
|
-$84.5M |
| 5 |
MDSL
M.D. Sass LLC
New York
|
-$72.3M |
